January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
ArriVent and Alphamab Partner in $615.5 million collaboration for Novel ADC Cancer Treatments – GeneOnline
Jun 8, 2024, 06:47

ArriVent and Alphamab Partner in $615.5 million collaboration for Novel ADC Cancer Treatments – GeneOnline

GeneOnline shared a post on LinkedIn:

ArriVent BioPharma and Alphamab Oncology announce a $615.5 million collaboration to develop and commercialize novel antibody-drug conjugates (ADCs) for cancer treatment. This partnership leverages cutting-edge ADC technology and global commercialization expertise.”

Further Reading.
Source: GeneOnline/LinkedIn